The great TPP deathtrap for India, China
And the other 10 member-nations
The terms of destruction
by Jon Rappoport
The clues are all there in Obamatrade and Obamacare
June 17, 2015
“Once in a while, a major leak oozes out of the government-corporate nexus. First responders and damage-control experts quickly arrive on the scene and throw a blanket over the shocking revelation. Media fall silent. Nothing happened. It was a momentary delusion. Everything is fine. To the degree that the public becomes aware of the truth, the public registers utter disbelief and denial. Why? Because believing this one thing would torpedo their faith in the whole structure of the synthetic invention called Reality.” (The Underground, Jon Rappoport)
The truth emerges out of the shadows of secrecy…
Let’s start here. The Trans-Pacific Partnership (TPP) is a trade treaty, coming down the homestretch toward ratification, involving 12 nations which account for a staggering 40% of the world’s GDP. The TPP encompasses 775 million consumers.
Waiting in the wings is something much larger. It is the intention, up the road, to fold India and China into the treaty.
China is the most populous nation in the world. 1.4 billion people. India is the second most populous. 1.28 billion people. India is projected to overtake and pass China by 2025.
During his seven years in office, the most publicly recognizable PR man in the world, Barack Obama, has sweated and hammered on two policies. Just two. He is now in a panic over forcing one of those: the TPP. The other one was Obamacare. That’s it. Everything else was a Sunday picnic in the park.
Obamacare, the US national health insurance plan, when you strip it down to basics, was about one thing: bowing to drug companies.
It brought huge numbers of new people, previously uninsured, into the game. Meaning those people would be able to take the drugs—and the prices for those drugs would remain high.
So it is with the TPP, as it turns out. One of the major priorities is forcing member countries to accept higher pricing on medical drugs. Which was exactly the deal in Obamacare. Big Pharma backed Obamacare for the express purpose of cutting out debates about lowering costs on drugs.
In that respect, Obamacare and the TPP are mirror images of each other.
One other vital detail: the TPP will also allow pharmaceutical companies to push drugs and force them into markets where, ordinarily, they could be rejected as unsafe.
The problem? Well, how about this: every year, in the US, by a conservative assessment, medical drugs kill 106,000 people.
That number comes from Dr. Barbara Starfield, who at the time (July 2000) was a revered public health expert working at the Johns Hopkins School of Public Health. Her assessment, “Is US health really the best in the world?”, was published on July 26, 2000, in the Journal of the American Medical Association.
I have often cited her review, and I’ve presented other references that back her up. In fact, if you go to a web page on the FDA’s own site, you will see a similar assessment of medical-drug devastation, including an estimate of non-lethal but debilitating harm:
The FDA website page states there are 2 million serious adverse reactions (ADRs) from the ingestion of medical drugs, annually, in the US. When the FDA says “serious,” they aren’t talking about headaches or slight dizziness or temporary nausea. “Serious” means, among other effects, stroke, heart attack, neurological damage; maiming of that magnitude.
Therefore, per decade, that adds up to 20 million ADRs. 20 million. In the US alone.
And a million deaths per decade in the US, caused by FDA-approved medical drugs.
Getting the picture?
Now here is the payoff, the bottom line: where, in the world, do traditional and older healing methods and remedies survive to the fullest degree?
To put it another way, what are the biggest uncaptured markets and populations that drug companies yearn for and dream about?
China.
India.
This is the future path of the TPP. This is where the Pharma-guided TPP wants to go most fervently. This is the ultimate prize in Pharma’s battle plan. This is the TPP jackpot.
This is ultimately where Pharma wants to replace traditional herbs with…what? Chemical death and destruction.
I put it that way because it’s true, when you eliminate the propaganda and look at the track record.
1.4 billion people in China. 1.28 billion people in India.
Would you care to extrapolate the death numbers? And the “serious adverse-effect” numbers. Per year? Per decade? For China and India combined? Do the math.
If in the US, with a population of 325 million, medical drugs kill 100,000 people per year, the number of deaths for the combined populations of India and China (2.68 billion people) comes out to 824,000 per year. 8.24 million deaths per decade.
Serious adverse drug reactions in a population of 2.68 billion? More than 16.4 million per year. More than 164 million per decade.
If you told some cold-eyed lunatic military planner you could achieve those results, with chemical warfare, on a sustained basis, year in and year out, with absolutely no detection, with no blowback, no criminal war trials, with enormous accrued profits, with claims of “curing disease,” he would jump out of his chair and order champagne and call you a genius.
That’s where we are. That’s what the TPP, up the road, is all about.
China and India are the ultimate targets. Make no mistake about it.
And waiting in the wings: Indonesia, with the fourth largest population in the world: 252 million people.
Let me know when you see the statistics cited in this article unequivocally presented in any major mainstream news outlet in the world, along with their relation to the TPP.
In the meantime, I’ll take a brief coffee break…and be back in a hundred years.
And the other 10 member-nations
The terms of destruction
by Jon Rappoport
The clues are all there in Obamatrade and Obamacare
June 17, 2015
“Once in a while, a major leak oozes out of the government-corporate nexus. First responders and damage-control experts quickly arrive on the scene and throw a blanket over the shocking revelation. Media fall silent. Nothing happened. It was a momentary delusion. Everything is fine. To the degree that the public becomes aware of the truth, the public registers utter disbelief and denial. Why? Because believing this one thing would torpedo their faith in the whole structure of the synthetic invention called Reality.” (The Underground, Jon Rappoport)
The truth emerges out of the shadows of secrecy…
Let’s start here. The Trans-Pacific Partnership (TPP) is a trade treaty, coming down the homestretch toward ratification, involving 12 nations which account for a staggering 40% of the world’s GDP. The TPP encompasses 775 million consumers.
Waiting in the wings is something much larger. It is the intention, up the road, to fold India and China into the treaty.
China is the most populous nation in the world. 1.4 billion people. India is the second most populous. 1.28 billion people. India is projected to overtake and pass China by 2025.
During his seven years in office, the most publicly recognizable PR man in the world, Barack Obama, has sweated and hammered on two policies. Just two. He is now in a panic over forcing one of those: the TPP. The other one was Obamacare. That’s it. Everything else was a Sunday picnic in the park.
Obamacare, the US national health insurance plan, when you strip it down to basics, was about one thing: bowing to drug companies.
It brought huge numbers of new people, previously uninsured, into the game. Meaning those people would be able to take the drugs—and the prices for those drugs would remain high.
So it is with the TPP, as it turns out. One of the major priorities is forcing member countries to accept higher pricing on medical drugs. Which was exactly the deal in Obamacare. Big Pharma backed Obamacare for the express purpose of cutting out debates about lowering costs on drugs.
In that respect, Obamacare and the TPP are mirror images of each other.
One other vital detail: the TPP will also allow pharmaceutical companies to push drugs and force them into markets where, ordinarily, they could be rejected as unsafe.
The problem? Well, how about this: every year, in the US, by a conservative assessment, medical drugs kill 106,000 people.
That number comes from Dr. Barbara Starfield, who at the time (July 2000) was a revered public health expert working at the Johns Hopkins School of Public Health. Her assessment, “Is US health really the best in the world?”, was published on July 26, 2000, in the Journal of the American Medical Association.
I have often cited her review, and I’ve presented other references that back her up. In fact, if you go to a web page on the FDA’s own site, you will see a similar assessment of medical-drug devastation, including an estimate of non-lethal but debilitating harm:
The FDA website page states there are 2 million serious adverse reactions (ADRs) from the ingestion of medical drugs, annually, in the US. When the FDA says “serious,” they aren’t talking about headaches or slight dizziness or temporary nausea. “Serious” means, among other effects, stroke, heart attack, neurological damage; maiming of that magnitude.
Therefore, per decade, that adds up to 20 million ADRs. 20 million. In the US alone.
And a million deaths per decade in the US, caused by FDA-approved medical drugs.
Getting the picture?
Now here is the payoff, the bottom line: where, in the world, do traditional and older healing methods and remedies survive to the fullest degree?
To put it another way, what are the biggest uncaptured markets and populations that drug companies yearn for and dream about?
China.
India.
This is the future path of the TPP. This is where the Pharma-guided TPP wants to go most fervently. This is the ultimate prize in Pharma’s battle plan. This is the TPP jackpot.
This is ultimately where Pharma wants to replace traditional herbs with…what? Chemical death and destruction.
I put it that way because it’s true, when you eliminate the propaganda and look at the track record.
1.4 billion people in China. 1.28 billion people in India.
Would you care to extrapolate the death numbers? And the “serious adverse-effect” numbers. Per year? Per decade? For China and India combined? Do the math.
If in the US, with a population of 325 million, medical drugs kill 100,000 people per year, the number of deaths for the combined populations of India and China (2.68 billion people) comes out to 824,000 per year. 8.24 million deaths per decade.
Serious adverse drug reactions in a population of 2.68 billion? More than 16.4 million per year. More than 164 million per decade.
If you told some cold-eyed lunatic military planner you could achieve those results, with chemical warfare, on a sustained basis, year in and year out, with absolutely no detection, with no blowback, no criminal war trials, with enormous accrued profits, with claims of “curing disease,” he would jump out of his chair and order champagne and call you a genius.
That’s where we are. That’s what the TPP, up the road, is all about.
China and India are the ultimate targets. Make no mistake about it.
And waiting in the wings: Indonesia, with the fourth largest population in the world: 252 million people.
Let me know when you see the statistics cited in this article unequivocally presented in any major mainstream news outlet in the world, along with their relation to the TPP.
In the meantime, I’ll take a brief coffee break…and be back in a hundred years.
No comments:
Post a Comment
Comments always welcome!